|
Volumn 115, Issue 3, 2002, Pages 398-401
|
Clinical analysis of 78 cases of paroxysmal nocturnal hemoglobinuria diagnosed in the past ten years
|
Author keywords
Clinical features; Diagnosis; Paroxysmal nocturnal hemoglobinuria; Treatment
|
Indexed keywords
CD59 ANTIGEN;
CORTICOSTEROID;
DANAZOL;
DECAY ACCELERATING FACTOR;
FLUOXYMESTERONE;
HEMOGLOBIN;
MELPHALAN;
PREDNISONE;
ADOLESCENT;
ADULT;
AGED;
ANTIGEN DETECTION;
ARTICLE;
BLOOD CELL;
BONE MARROW DEPRESSION;
BONE MARROW HYPOPLASIA;
CHILD;
CLINICAL FEATURE;
DOSE RESPONSE;
DRUG EFFICACY;
FAMILY HISTORY;
FEMALE;
HEMOGLOBINURIA;
HEREDITY;
HUMAN;
KARYOTYPE;
LABORATORY TEST;
MAJOR CLINICAL STUDY;
MALE;
MYELODYSPLASIA;
ONSET AGE;
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA;
RELAPSE;
RETROSPECTIVE STUDY;
SENSITIVITY AND SPECIFICITY;
SEX DIFFERENCE;
SISTER CHROMATID EXCHANGE;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
CHILD;
FEMALE;
HEMOGLOBINURIA, PAROXYSMAL;
HUMANS;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
|
EID: 0036202869
PISSN: 03666999
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (18)
|
References (11)
|